-
2
-
-
0028814081
-
Vitamin D
-
D. Fraser. Vitamin D. The Lancet 345: 104-107 (1995).
-
(1995)
The Lancet
, vol.345
, pp. 104-107
-
-
Fraser, D.1
-
3
-
-
0026589941
-
Calcipotriol. A review of its pharmaceutical properties and therapeutic use in psoriasis vulgaris
-
D. Murdoch and S. Clissold. Calcipotriol. A review of its pharmaceutical properties and therapeutic use in psoriasis vulgaris. Drugs 43: 415-29 (1992).
-
(1992)
Drugs
, vol.43
, pp. 415-429
-
-
Murdoch, D.1
Clissold, S.2
-
4
-
-
0028842723
-
Calcipotriol: A new drug for topical psoriasis treatment
-
K. Kragbelle. Calcipotriol: a new drug for topical psoriasis treatment. Pharmacol. Toxicol. 77: 241-46 (1995).
-
(1995)
Pharmacol. Toxicol.
, vol.77
, pp. 241-246
-
-
Kragbelle, K.1
-
5
-
-
0542366905
-
Calcipotriol, nieuwe therapie voor psoriasis
-
C. Debaille. Calcipotriol, nieuwe therapie voor psoriasis. Het Apothekersblad 2: 29-32 (1994).
-
(1994)
Het Apothekersblad
, vol.2
, pp. 29-32
-
-
Debaille, C.1
-
6
-
-
0027416427
-
Calcipotriol. A new topical antipsoriatic
-
K. Kragbelle and L. Iversen. Calcipotriol. A new topical antipsoriatic. Dermatol. Clin. 11: 137-41 (1993).
-
(1993)
Dermatol. Clin.
, vol.11
, pp. 137-141
-
-
Kragbelle, K.1
Iversen, L.2
-
8
-
-
0025055156
-
In vitro metabolism of Calcipotriol (MC 903), a Vitamin D analogue
-
H. Sorensen, L. Binderup, M. Calverly, L. Hoffmeyer, and N. Andersen. In vitro metabolism of Calcipotriol (MC 903), a Vitamin D analogue. Biochem. Pharmacol. 39: 391-93 (1990).
-
(1990)
Biochem. Pharmacol.
, vol.39
, pp. 391-393
-
-
Sorensen, H.1
Binderup, L.2
Calverly, M.3
Hoffmeyer, L.4
Andersen, N.5
-
10
-
-
85034459963
-
-
US Pharmacopeial Convention, Rockville, MD
-
United States Pharmacopoeia, 22nd revision. US Pharmacopeial Convention, Rockville, MD, 1990, pp 303-304.
-
(1990)
Pharmacopoeia, 22nd Revision
, pp. 303-304
-
-
-
11
-
-
0023793559
-
3 in pharmaceutical preparations and in blood
-
3 in pharmaceutical preparations and in blood. J. Chromatogr. 11: 1347-57 (1988).
-
(1988)
J. Chromatogr.
, vol.11
, pp. 1347-1357
-
-
Amin, M.1
-
12
-
-
0017982611
-
Classification of solvent properties of common liquids
-
L. Snyder. Classification of solvent properties of common liquids. J. Chromatogr. Sci. 16: 223-34 (1978).
-
(1978)
J. Chromatogr. Sci.
, vol.16
, pp. 223-234
-
-
Snyder, L.1
-
13
-
-
17344394035
-
Calcipotriol (Daivonex)
-
C. Doelman. Calcipotriol (Daivonex). Pharm. Weekblad 128: 644-46 (1993).
-
(1993)
Pharm. Weekblad
, vol.128
, pp. 644-646
-
-
Doelman, C.1
-
14
-
-
85022961685
-
Optimization of solvent strength and selectivity for reversed-phase liquid chromatography using an interactive mixture-design statistical technique
-
J.L. Glajch, J.J. Kirkland, and K.M. Squire. Optimization of solvent strength and selectivity for reversed-phase liquid chromatography using an interactive mixture-design statistical technique. J. Chromatogr. 199: 57-79 (1980).
-
(1980)
J. Chromatogr.
, vol.199
, pp. 57-79
-
-
Glajch, J.L.1
Kirkland, J.J.2
Squire, K.M.3
-
15
-
-
0542414287
-
The practice of high performance LC with four solvents
-
R. Lehrer. The practice of high performance LC with four solvents. International Laboratory November/December: 76-88 (1981).
-
(1981)
International Laboratory
, vol.NOVEMBER-DECEMBER
, pp. 76-88
-
-
Lehrer, R.1
-
16
-
-
0028087967
-
High dose topical Calcipotriol consistently reduces serum parathyroid hormone levels
-
J. Bourke, J. Berth-Jones, R. Mumford, and P. Hutchinson. High dose topical Calcipotriol consistently reduces serum parathyroid hormone levels. Clin. Endocrinol. Oxf. 41: 295-97 (1994).
-
(1994)
Clin. Endocrinol. Oxf.
, vol.41
, pp. 295-297
-
-
Bourke, J.1
Berth-Jones, J.2
Mumford, R.3
Hutchinson, P.4
-
17
-
-
85034480404
-
-
Council of Europe, Maisonneuve SA, Sainte-Ruffine, France
-
European Pharmacopoiea, 2nd ed., Part II. Council of Europe, Maisonneuve SA, Sainte-Ruffine, France, 1995, p V.6.20.4.
-
(1995)
European Pharmacopoiea, 2nd Ed.
, Issue.2 PART
-
-
|